Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy
worldwide, affecting approximately 1 in 500 individuals. Current therapeutic interventions …

Inherited cardiovascular diseases pose unique and complex psychosocial challenges for
families, including coming to terms with life-long cardiac disease, risk of sudden death, grief …

Importance Racial differences are recognized in multiple cardiovascular parameters,
including left ventricular hypertrophy and heart failure, which are 2 major manifestations of …

Background Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined
by left ventricular hypertrophy that cannot be explained by another cardiac or systemic …

Patient-reported outcome measures (PROMs) are used to facilitate patient-centered care
(PCC). While studies in patients with cardiac conditions have revealed poorer health-related …

Ongoing challenges of clinical assessment of long QT syndrome (LQTS) highlight the
importance of genetic testing in the diagnosis of asymptomatic at‐risk family members …

Hypertrophic cardiomyopathy (HCM) is a hereditary cardiac condition characterized by
unexplained left ventricular hypertrophy without a hemodynamic cause. This condition is …

With the surge of next-generation sequencing (NGS) technologies making almost all genetic
tests more affordable and available, cardiac genetic testing now routinely encompasses a …

In addition to genetic data, precision medicine research gathers information about three
factors that modulate gene expression: lifestyles, environments, and communities. The …

The field of cardiovascular genetic counseling has evolved dramatically in recent years
largely to manage the unique psychological needs of the inherited cardiovascular disease …